Stereotactic Body Radiation Therapy Treatment Plans Research Articles

Efficacious patient-specific QA for Vertebra SBRT using a high-resolution detector array SRS MapCHECK: AAPM TG-218 analysis.

Patient-specific quality assurance (PSQA) for vertebra stereotactic body radiation therapy (SBRT) presents challenges due to highly modulated small fields with high-dose gradients between the target and spinal cord. This study aims to explore the use of the SRS MapCHECK® (SRSMC) for vertebra SBRT PSQA. Twenty vertebra SBRT treatment plans including prescriptions 20Gy/1 fraction and 24Gy/2 fractions were selected for each of Millennium (M)-Multileaf Collimator (MLC), and high-definition (HD)-MLC. All 40 plans were measured using Gafchromic EBT3 film (film) and SRSMC, using the StereoPHAN phantom. Plan complexity was assessed using modulation complexity score (MCS), edge metric (EM) (mm-1), modulation factor (MU/cGy), and average leaf pair opening (ALPO) (mm) and its correlation with gamma-pass rate was investigated. The high dose gradient between the target and the spinal cord was analyzed for film and SRSMC and compared against the treatment planning system (TPS). Applying the methodology proposed by AAPM TG-218, action and tolerance values specific to the SRSMC for vertebra SBRT were determined for β values ranging from 5 to 8. Film and SRSMC gamma-pass rates showed no correlation (p>0.05). A moderate negative correlation (R=-0.57, p=0.01) is present between EM and SRSMC 3%/1mm gamma-pass rate for HD-MLC plans. Both film and SRSMC accurately measured high dose gradients between the target and the spinal cord (R2>0.86, p ≤ 0.05). Notably, dose-gradient of HD-MLC plans is 22% steeper and has a smaller standard deviation to M-MLC plans (p ≤ 0.05). Applying TG-218, the film tolerance limit was 96% with action limit 95% for 5%/1mm (β=6) and for the SRSMC tolerance limit was 97% with an action limit of 96% for 4%/1mm (β=6). Our findings suggest that universal TG-218 limits may not be suitable for vertebra SBRT PSQA. This study demonstrates that SRSMC is a viable tool for vertebra SBRT PSQA, supported by TG-218 implementation of process-based tolerance and action limits.

A novel lung SBRT treatment planning: Inverse VMAT plan with leaf motion limitation to ensure the irradiation reproducibility of a moving target

This study exposed the implementation of a novel technique (VMATLSL) for the planning of moving targets in lung stereotactic body radiation therapy (SBRT). This new technique has been compared to static conformal radiotherapy (3D-CRT), volumetric-modulated arc therapy (VMAT), and dynamic conformal arc (DCA). The rationale of this study was to lower geometric complexity (54.9% lower than full VMAT) and hence ensure the reproducibility of the treatment delivery by reducing the risk for interplay errors induced by respiratory motion. Dosimetry metrics were studied with a cohort of 30 patients. Our results showed that leaf speed limitation provided conformal number (CN) close to the VMAT (median CN of VMATLSL is 0.78 vs 0.82 for full VMAT) and was a significant improvement on 3D-CRT and DCA with segment-weight optimized (respectively 0.55 and 0.57). This novel technique is an alternative to VMAT or DCA for lung SBRT treatments, combining independence from the patient's breathing pattern, from the size and amplitude of the lesion, free from interplay effect, and with dosimetry metrics close to the best that could be achieved with full VMAT.

Dosimetric Impact of Radiolucent Carbon Fiber Hardware for Post-Operative Spine Stereotactic Body Radiation Therapy

The spine is the most common site of osseous metastases. In the non-operative setting, there is growing support for stereotactic body radiation therapy (SBRT) over conventional radiation therapy for improved pain relief and local control. Hybrid therapy consisting of separation surgery and post-operative SBRT is considered in patients with biomechanical instability and epidural cord compression. Surgery traditionally requires titanium (Ti) implants, which introduce artifacts on post-operative imaging in addition to increased uncertainty and beam attenuation. Use of radiolucent carbon fiber reinforced polyetheretherketone (CFR-PEEK) hardware has been shown to provide safe and comparable surgical outcomes as compared to Ti. Our primary objective is to assess the dosimetric impact of Ti versus carbon fiber implants in spine SBRT. Single institution retrospective series of post-operative spine SBRT from 2019-2020. Re-irradiation cases were excluded. The electronic medical record and treatment planning systems (TPS) were queried. Dosimetric analyses compared original Ti plans with reoptimized plans, replacing Ti hardware electronic density with carbon fiber. Maintaining clinical goals, dose calculations were performed in a treatment planning system using a collapsed cone algorithm. All treatments used step and shoot intensity modulated radiation therapy to avoid beam angles with significant metal along the beam path. Metallic artifacts were contoured and assigned the appropriate tissue density. A D'Agostino-Pearson test was used to assess data for normality. We used paired Student's t-tests to compare three dosimetric outcomes in the setting of Ti and carbon fiber implants. Planning target volume (PTV) coverage was represented by the volume receiving at least the prescribed dose (%), the maximum point dose (dmax, cGy) to the spinal cord planning risk volume (PRV, 2 mm margin), and the overall hot spot intensity (plan dmax). A series of 14 consecutive SBRT cases were evaluated (dose 27-30 Gy in 3-5 fractions). All dosimetric outcomes were normally distributed (p>0.05). We found a statistically significant difference in PTV coverage between the original SBRT treatment plans with Ti hardware (mean 85.1 ± 7.9%) and reoptimized carbon fiber hardware (87.3 ± 6.6%; p = 0.002). There was no significant difference in mean spinal cord PRV dmax between Ti and carbon fiber plans (1846 ± 483 cGy vs. 1842 ± 495 cGy; p>0.05). We observed a nonsignificant increase in mean overall dmax from 3932 ± 416 cGy in the Ti cohort to 4111 ± 906 cGy in the carbon fiber cohort (p>0.05). Carbon fiber implants provide a significant increase in SBRT target coverage, without impacting the overall plan and spinal cord PRV dmax in this retrospective series. In addition to improved post-operative imaging and reduced uncertainty, carbon fiber hardware may offer dosimetric advantages as compared to traditional Ti spinal implants, and warrants further investigation in a larger cohort.

293 Prostate Stereotactic Body Radiotherapy Treatment Planning and Image Guidance: Initial Experience from Two Institutions

293 Prostate Stereotactic Body Radiotherapy Treatment Planning and Image Guidance: Initial Experience from Two Institutions

Static couch non-coplanar arc selection optimization for lung SBRT treatment planning

Objective. Non-coplanar arc geometry optimizations that take advantage of beam’s eye view (BEV) geometric overlap information have been proven to reduce dose to healthy organs-at-risk (OARs). Recently, a metric called mean arc distance (MAD) has been developed that quantifies the arc geometry sampling of 4π space. The purpose of this research is to combine improved BEV overlap information with MAD to generate static couch lung stereotactic body radiotherapy (SBRT) treatment plans deliverable on a C-arm linear accelerator. Approach. An algorithm utilizing the Moller–Trumbore ray-triangle intersection method was employed to compute a cost surrogate for dose to overlapping OARs using distances interpolated onto a PDD. Cost was combined with MAD for 100 000 random combinations of arc trajectories. A pathfinding algorithm for arc selection was created, balancing the contributions of MAD and 4π cost for the final trajectory. This methodology was evaluated for 18 lung SBRT patients. Cases were also planned with arcs from a clinical treatment template protocol for dosimetric and plan quality comparison. Results were evaluated using dose constraints in the context of RTOG0915. Main results. Five of six OARs had maximum dose reductions when planned with the arc trajectory optimization algorithm. Significant maximum dose reductions were found for esophagus (7.41 ± 0.91 Gy, p = 0.00019), trachea (5.56 ± 1.55 Gy, p = 0.0025), spinal cord (2.87 ± 1.13 Gy, p = 0.039), large bronchus (3.47 ± 1.49 Gy, p = 0.0075), and aorta (3.13 ± 0.99 Gy, p = 0.012). Mean dose to contralateral lung was also significantly reduced (0.50 ± 0.06 Gy, p = 0.00019). There were two significant increases in OAR doses: mean dose to ipsilateral lung (0.40 ± 0.09, p = 0.00086) and V5Gy to ipsilateral lung (1.95 ± 0.70%, p = 0.011). Paddick conformity index increased by 0.03 ± 0.02 (p = 0.14), remaining below a limit of 1.2 for both techniques. Significance. Static couch non-coplanar optimization yielded maximum dose reductions to OARs while maintaining target conformity for lung SBRT.

The effect of integrating knowledge-based planning with multicriteria optimization in treatment planning for prostate SBRT.

Knowledge-based planning (KBP) and multicriteria optimization (MCO) are two powerful tools to assist treatment planners in achieving optimal target coverage and organ-at-risk (OAR) sparing. The purpose of this work is to investigate if integrating MCO with conventional KBP can further improve treatment plan quality for prostate cancer stereotactic body radiation therapy (SBRT). A two-phase study was designed to investigate the impact of MCO and KBP in prostate SBRT treatment planning. The first phase involved the creation of a KBP model based on thirty clinical SBRT plans, generated by manual optimization (KBP_M). A ten-patient validation cohort was used to compare manual, MCO, and KBP_M optimization techniques. The next phase involved replanning the original model cohort with additional tradeoff optimization via MCO to create a second model, KBP_MCO. Plans were then generated using linear integration (KBP_M+MCO), non-linear integration (KBP_MCO), and a combination of integration methods (KBP_MCO+MCO). All plans were analyzed for planning target volume (PTV) coverage, OAR constraints, and plan quality metrics. Comparisons were generated to evaluate plan and model quality. Phase 1 highlighted the necessity of KBP and MCO in treatment planning, as both optimization methods improved plan quality metrics (Conformity and Heterogeneity Indices) and reduced mean rectal dose by 2Gy, as compared to manual planning. Integrating MCO with KBP did not further improve plan quality, as little significance was seen over KBP or MCO alone. Principal component score (PCS) fitting showed KBP_MCO improved bladder and rectum estimated and modeled dose correlation by 5% and 22%, respectively; however, model improvements did not significantly impact plan quality. KBP and MCO have shown to reduce OAR dose while maintaining desired PTV coverage in this study. Further integration of KBP and MCO did not show marked improvements in treatment plan quality while requiring increased time in model generation and optimization time.

Lung SBRT treatment planning: a study of VMAT arc selection guided by collision check software.

To evaluate the effects of arc geometry on lung stereotactic body radiation therapy (SBRT) plan quality, using collision check software to select safe beam angles. Thirty lung SBRT cases were replanned 10Gy x 5 using 4 volumetric modulated arc therapy (VMAT) geometries: coplanar lateral (cpLAT), coplanar oblique (cpOBL), noncoplanar lateral (ncpLAT) and noncoplanar oblique (ncpOBL). Lateral arcs spanned 180° on the affected side whereas the 180° oblique arcs crossed midline to spare healthy tissues. Couch angles were separated by 30° on noncoplanar plans. Clearance was verified with Radformation CollisionCheck software. Optimization objectives were the same across the four plans for each case. Planning target volume (PTV) coverage was set to 95% and then plans were evaluated for dose conformity, healthy tissue doses, and monitor units. Clinically treated plans were used to benchmark the results. The volumes of the 25%, 50% and 75% isodoses were smaller with noncoplanar than coplanar arcs. The volume of the 50% isodose line relative to the PTV (CI50%) was as follows: clinical 3.75±0.72, cpLAT 3.39 ± 0.37, cpOBL 3.36 ± 0.34, ncpLAT 3.02 ± 0.21 and ncpOBL 3.02 ± 0.22. The Wilcoxon signed rank test with Bonferroni correction showed p < 0.005 in all CI50% comparisons except between the cpLat and cpObl arcs and between the ncpLat and ncpObl arcs. The best lung sparing was achieved using ncpObl arcs, which was statistically significant (p < 0.001) compared with the other four plans at V12.5Gy, V13.5Gy and V20Gy. Chest wall V30Gy was significantly better using noncoplanar arcs in comparison to the other plan types (p < 0.001). The best heart sparing at V10Gy from the ncpOBL arcs was significant compared with the clinical and cpLat plans (p < 0.005). Arc geometry has a substantial effect on lung SBRT plan quality. Noncoplanar arcs were superior to coplanar arcs at compacting the dose distribution at the 25%, 50% and 75% isodose levels, thereby reducing the dose to healthy tissues. Further healthy tissue sparing was achieved using oblique arcs that minimize the pathlength through healthy tissues and avoid organs at risk. The dosimetric advantages of the noncoplanar and oblique arcs require careful beam angle selection during treatment planning to avoid collisions during treatment, which may be facilitated by commercial software.

Effects of reconstruction methods on dose distribution for lung stereotactic body radiotherapy treatment plans.

The aim of the present study was to investigate the effect of tumour motion on various imaging strategies as well as on treatment plan accuracy for lung stereotactic body radiotherapy treatment (SBRT) cases. The ExacTrac gating phantom and paraffin were used to investigate respiratory motion and represent a lung tumour, respectively. Four-dimensional computed tomography (4DCT) imaging was performed, while the phantom was moving sinusoidally with 4s cycling time with three different amplitudes of 8, 16, and 24mm. Reconstructions were done with maximum (MIP) and average intensity projection (AIP) methods. Comparisons of target density and volume were performed using two reconstruction techniques and references values. Volumetric modulated arc therapy (VMAT) and intensity modulated radiation therapy (IMRT) were planned based on reconstructed computed tomography (CT) sets, and it was examined how density variations affect the dose-volume histogram (DVH) parameters. 4D cone beam computed tomography (CBCT) was performed with the Elekta Versa HD linac imaging system before irradiation and compared with 3D CBCT. Thus, various combinations of 4DCT reconstruction methods and treatment alignment methods have been investigated. Point measurements as well as 2 and 3D dose measurements were done by optically stimulated luminescence (OSL), gafchromic films, and electronic portal imaging devices (EPIDs), respectively. The mean volume reduction was 7.8% for the AIP and 2.6% for the MIP method. The obtained Hounsfield Unit (HU) values were lower for AIP and higher for MIP when compared with the reference volume density. In DVH analysis, there were no statistical differences for D95%, D98%, and Dmean (p > 0.05). However, D2% was significantly affected by HU changes (p < 0.01). A positional variation was obtained up to 2mm in moving direction when 4D CBCT was applied after 3D CBCT. Dosimetric measurements showed that the main part of the observed dose deviation was due to movement. In lung SBRT treatment plans, D2% doses differ significantly according to the reconstruction method. Additionally, it has been observed that setups based on 3D imaging can cause a positional error of up to 2mm compared to setups based on 4D imaging. It is concluded that MIP has advantages over AIP in defining internal target volume (ITV) in lung SBRT applications. In addition, 4D CBCT and 3D EPID dosimetry are recommended for lung SBRT treatments.

Role of Functional MRI in Liver SBRT: Current Use and Future Directions.

Stereotactic body radiation therapy (SBRT) is an emerging treatment for liver cancers whereby large doses of radiation can be delivered precisely to target lesions in 3-5 fractions. The target dose is limited by the dose that can be safely delivered to the non-tumour liver, which depends on the baseline liver functional reserve. Current liver SBRT guidelines assume uniform liver function in the non-tumour liver. However, the assumption of uniform liver function is false in liver disease due to the presence of cirrhosis, damage due to previous chemo- or ablative therapies or irradiation, and fatty liver disease. Anatomical information from magnetic resonance imaging (MRI) is increasingly being used for SBRT planning. While its current use is limited to the identification of target location and size, functional MRI techniques also offer the ability to quantify and spatially map liver tissue microstructure and function. This review summarises and discusses the advantages offered by functional MRI methods for SBRT treatment planning and the potential for adaptive SBRT workflows.

Contour similarity and its implication on inverse prostate SBRT treatment planning.

Success of auto-segmentation is measured by the similarity between auto and manual contours that is often quantified by Dice coefficient (DC). The dosimetric impact of contour variability on inverse planning has been rarely reported. The main aim of this study is to investigate whether automatically generated organs-at-risk (OARs) could be used in inverse prostate stereotactic body radiation therapy (SBRT) planning and whether the dosimetric parameters are still clinically acceptable after radiation oncologists modify the OARs. Planning computed tomography images from 10 patients treated with SBRT for prostate cancer were selected and automatically segmented by commercially available atlas-based software. The automatically generated OAR contours were compared with the manually drawn contours. Two volumetric modulated arc therapy (VMAT) plans, autoRec-VMAT (where only automatically generated rectums were used in optimization) and autoAll-VMAT (where automatically generated OARs were used in inverse optimization) were generated. Dosimetric parameters based on the manually drawn PTV and OARs were compared with the clinically approved plans. The DCs for the rectum contours varied from 0.55 to 0.74 with a mean value of 0.665. Differences of D95 of the PTV between autoRec-VMAT and manu-VMAT plans varied from 0.03% to -2.85% with a mean value of -0.64%. Differences of D0.03cc of manual rectum between the two plans varied from -0.86% to 9.94% with a mean value of 2.71%. D95 of PTV between autoAll-VMAT and manu-VMAT plans varied from 0.28% to -2.9% with a mean value -0.83%. Differences of D0.03cc of manual rectum between the two plans varied from -0.76% to 6.72% with a mean value of 2.62%. Our study implies that it is possible to use unedited automatically generated OARs to perform initial inverse prostate SBRT planning. After radiation oncologists modify/approve the OARs, the plan qualities based on the manually drawn OARs are still clinically acceptable, and a re-optimization may not be needed.

Neuromuscular Toxicity and Dose-Volume Relationships Following SBRT for Bone Oligometastases: Post-Hoc Analysis of Two Ongoing Clinical Trials

<h3>Purpose/Objective(s)</h3> Growing evidence suggests that stereotactic body radiotherapy (SBRT) is effective for oligometastatic disease. Currently, there is limited data to define dose-volume relationships between muscle and adipose tissues and neuromuscular toxicities. In this post hoc analysis, we evaluated these associations in patients enrolled in two phase II clinical trials (NCT03575611, NCT03599765) where bone oligometastases were ablated with SBRT. <h3>Materials/Methods</h3> We reviewed three-fraction SBRT treatment plans for bone oligometastases where total dose ranged from 24-36 Gy. We contoured muscle and adjacent soft tissue receiving at least 10Gy based on anatomical function (e.g., hip flexors) and defined the largest-volume group as the most-affected functional muscle group (MFMG). Muscle and adipose tissues within MFMGs (MFMG-m and MFMG-a respectively) were further delineated by semi-automated contouring scripts using previously validated CT Hounsfield unit ranges for muscle (-29 to +150 HU) and adipose (-190 to -30 HU). Associations between neuromuscular adverse events (AE) (graded by Common Terminology Criteria for Adverse Events version 5) with dose to 2cc-30cc of contoured volumes (D2cc-D30cc) and clinical variables (BMI, ECOG, etc.) were assessed using two-sided Mann-Whitney U tests. Results were considered significant at P<0.0071 with Bonferroni correction. <h3>Results</h3> We evaluated 43 treatment plans for 37 patients with target lesions in the pelvic girdle (n=18), rib (n=15), femur (n=4), lumbar vertebra (n=2), scapula (n=2), and sternum (n=2). Three patients (8.1%) experienced grade 3 hip pain, 1 patient (2.7%) had grade 2 hip pain, and 2 patients (5.4%) had grade 1 hip or rib pain. There were no grade 4 or 5 AEs. Median time to AE was 2.3 months (range: 1.2–4.5 months). Patients with AEs had significantly higher MFMG D25cc (median = 28.4 vs 18.6Gy; p=0.004), MFMG-m D25cc (median = 27.7 vs 17.3Gy; p=0.006), and MFMG-a D5cc (median = 30.2 vs 18.9Gy; p=0.006) compared to pain-free patients. We identified a dose/volume threshold at MFMG D25cc > 25 Gy, where 5/11 (45.5%) treatment plans above and 1/32 (3.1%) below this threshold led to AEs, corresponding to an odds ratio of 25.8. There was no relationship between AEs and BMI, ECOG score, or demographics. No local tumor recurrences occurred with median follow-up of 15.5 months (range: 3.1–35.4 months). Two patients with grade 3 AEs after SBRT to pelvic girdle lesions had 3- and 5-month follow-up MRIs which identified soft tissue edema consistent with our findings. <h3>Conclusion</h3> Preliminary results from two prospective trials suggests that SBRT for bone oligometastases can be conducted safely with excellent tumor control and minimal toxicity. We propose that MFMG D25cc be limited to 25 Gy to avoid symptomatic neuromuscular toxicity. Future studies are needed for dose criteria verification.

Transit dosimetry of stereotactic body radiotherapy treatments with electronic portal dosimetry device in patient with spinal implant.

In recent years, the use of the Electronic Portal Imaging Device (EPID) as an in vivo dosimeter has become widespread. However, reports of EPID for stereotactic body radiotherapy (SBRT) applications is scarce. There is no data on this topic especially when there are high-density materials in the radiation field. In this study, we aimed to investigate the dose distributions of SBRT treatment plans in patients with spinal implants by transit EPID dosimetry. Implants were inserted in phantoms that mimic the vertebrae, and VMAT plans were created on the phantoms to deliver 16Gy radiation doses to the target in 1 fraction. Transit EPID measurements were performed for each irradiation. The results were compared with the treatment planning system using the gamma analysis method. According to the gamma analysis results, while the non-implant model met the acceptance criteria with a rate of 95.4%, the implanted models did not pass the test with results between the rates of 70% to 73%. In addition, while the dose difference in the isocenter was 1.3% for the non-implanted model, this difference was observed to be between 7 and 8% in the implanted models. Our study revealed that EPID can be used as transit dosimetry for the VMAT-SBRT applications. However, unacceptable dose differences were obtained by transit EPID dosimetry in the VMAT-SBRT applications of patients with an implant. In the treatment of such patients, alternative treatment methods should be preferred in which the interaction of the implants with radiation can be prevented.

State-of-the-Art Imaging Techniques in Metastatic Spinal Cord Compression.

Simple SummaryMetastatic Spinal Cord Compression (MSCC) is a feared complication in oncology patients due to its potential for severe pain, permanent neurological disability and mechanical instability of the spine. This narrative review, conducted by keyword searches in PubMed and Google Scholar databases, aims to describe the important role of imaging in MSCC diagnosis and treatment. Diagnosis is typically achieved via Magnetic Resonance Imaging (MRI), although Computed Tomography (CT) Myelogram and conventional CT imaging can be performed in certain clinical situations. Metal artifact reduction techniques for MRI and CT are continually being researched to facilitate imaging in MSCC patients with spinal implants. Imaging also has an important role in pre-treatment planning, in-room image-guidance, and post-treatment follow-up for MSCC patients treated with stereotactic body radiotherapy. Recent advances in deep learning tools for image analysis can reduce the time to MSCC diagnosis, enabling earlier treatment for superior functional outcomes.Metastatic Spinal Cord Compression (MSCC) is a debilitating complication in oncology patients. This narrative review discusses the strengths and limitations of various imaging modalities in diagnosing MSCC, the role of imaging in stereotactic body radiotherapy (SBRT) for MSCC treatment, and recent advances in deep learning (DL) tools for MSCC diagnosis. PubMed and Google Scholar databases were searched using targeted keywords. Studies were reviewed in consensus among the co-authors for their suitability before inclusion. MRI is the gold standard of imaging to diagnose MSCC with reported sensitivity and specificity of 93% and 97% respectively. CT Myelogram appears to have comparable sensitivity and specificity to contrast-enhanced MRI. Conventional CT has a lower diagnostic accuracy than MRI in MSCC diagnosis, but is helpful in emergent situations with limited access to MRI. Metal artifact reduction techniques for MRI and CT are continually being researched for patients with spinal implants. Imaging is crucial for SBRT treatment planning and three-dimensional positional verification of the treatment isocentre prior to SBRT delivery. Structural and functional MRI may be helpful in post-treatment surveillance. DL tools may improve detection of vertebral metastasis and reduce time to MSCC diagnosis. This enables earlier institution of definitive therapy for better outcomes.

Prostate MRI in Stereotactic Body Radiation Treatment Planning and Delivery for Localized Prostate Cancer.

Prostate MRI is increasingly being used to make diagnoses and guide management for patients receiving definitive radiation treatment for prostate cancer. Radiologists should be familiar with the potential uses of prostate MRI in radiation therapy planning and delivery. Radiation therapy is an established option for the definitive treatment of localized prostate cancer. Stereotactic body radiation therapy (SBRT) is an external-beam radiation therapy method used to deliver a high dose of radiation to an extracranial target in the body, often in five or fewer fractions. SBRT is increasingly being used for prostate cancer treatment and has been recognized by the National Comprehensive Cancer Network as an acceptable definitive treatment regimen for low-, intermediate-, and high-risk prostate cancer. MRI is commonly used to aid in prostate radiation therapy. The authors review the uses of prostate MRI in SBRT treatment planning and delivery. Specific topics discussed include the use of prostate MRI for identification of and dose reduction to the membranous and prostatic urethra, which can decrease the risk of acute and late toxicities. MRI is also useful for identification and appropriate dose coverage of the prostate apex and areas of extraprostatic extension or seminal vesicle invasion. In prospective studies, prostate MRI is being validated for identification of and dose intensification to dominant intraprostatic lesions, which potentially can improve oncologic outcomes. It also can be used to evaluate the placement of fiducial markers and hydrogel spacers for radiation therapy planning and delivery. ©RSNA, 2022.

A data-driven approach to optimal beam/arc angle selection for liver stereotactic body radiation therapy treatment planning.

Stereotactic body radiation therapy (SBRT) for liver cancer has shown promising therapeutic effects. Effective treatment relies not only on the precise delivery provided by image-guided radiation therapy (IGRT) but also high dose gradient formed around the treatment volume to spare functional liver tissue, which is highly dependent on the beam/arc angle selection. In this study, we aim to develop a decision support model to learn human planner's beam navigation approach for beam angle/arc angle selection for liver SBRT. A total of 27 liver SBRT/HIGRT patients (10 IMRT, 17 VMAT/DCA) were included in this study. A dosimetric budget index was defined for each beam angle/control point considering dose penetration through the patient body and liver tissue. Optimal beam angle setting (beam angles for IMRT and start/terminal angle for VMAT/DCA) was determined by minimizing the loss function defined as the sum of total dosimetric budget index and beam span penalty function. Leave-one-out validation was exercised on all 27 cases while weighting coefficients in the loss function was tuned in nested cross validation. To compare the efficacy of the model, a model plan was generated using automatically generated beam setting while retaining the original optimization constraints in the clinical plan. Model plan was normalized to the same planning target volume (PTV) V100% as the clinical plans. Dosimetric endpoints including PTV D98%, D2%, liver V20Gy and total MU were compared between two plan groups. Wilcoxon Signed-Rank test was performed with the null hypothesis being that no difference exists between two plan groups. Beam setting prediction was instantaneous. Mean PTV D98% was 91.3% and 91.3% (P=0.566), while mean PTV D2% was 107.9% and 108.1% (P=0.164) for clinical plan and model plan respectively. Liver V20Gy showed no significant difference (P=0.590) with 23.3% for clinical plan and 23.4% for the model plan. Total MU is comparable (P=0.256) between the clinical plan (avg. 2,389.6) and model plan (avg. 2,319.6). The evidence driven beam setting model yielded similar plan quality as hand-crafted clinical plan. It is capable of capturing human's knowledge in beam selection decision making. This model could facilitate decision making for beam angle selection while eliminating lengthy trial-and-error process of adjusting beam setting during liver SBRT treatment planning.

How Does the Gradient Measure of the Lung SBRT Treatment Plan Depend on the Tumor Volume and Shape?

PurposeGradient measure (GM) is a critical index related to normal tissue sparing in radiosurgery. This study aims to describe the dependence of GM on target volume and target shape for lung stereotactic body radiation therapy (SBRT) treatment plans.MethodsA total of 307 peripheral and 119 central lung SBRT treatment plans were enrolled for this study. A least-squares regression was used for data analysis. First, the equations with different functional forms were established to determine the dependence of GM on a univariaty (VP or Sp) and bivariaty (VP and Sp), respectively. Then, the correlation coefficients and p-values of variables for all equations were compared and analyzed to determine the dependence of GM on PTV volume (VP) and sphericity (Sp).ResultsThe power equations had the highest coefficient of determination (R2) in the dependence results of GM on univariate VP. The equations were and for peripheral and central lesions, respectively. On the other hand, the R2 of all functional forms were less than 0.25 when the relationship of GM versus univariate Sp was analyzed. Similarly, the power equation also obtained the highest R2 in bivariaty VP and Sp analysis, whether for central or peripheral. However, the R2 of the bivariate equations were not improved compared with those of univariate equations. Moreover, the p-values of the variable Sp were greater than 0.05.ConclusionsThe GM of the lung SBRT plan is shape-independent and volume-dependent. The dependence of GM on PTV volume for peripheral and central lung cancer can be described by two different power equations. The results of this study can be used as a potential tool to assist dosimetric quality control during the radiosurgery process.

An AI-Enabled Virtual Hands-On Teaching Tool for Treatment Planning: A Pancreas SBRT Pilot Study

<h3>Purpose/Objective(s)</h3> To develop a tutoring program to help physician and physics residents to learn pancreas stereotactic body radiation therapy (SBRT) treatment planning via carefully collected cases and a series of specially designed knowledge models as teaching aid. Such programs are especially important during the Covid pandemic when most traditional hands-on medical teaching had to be moved online and asynchronous. <h3>Materials/Methods</h3> The pilot tutoring program was composed of 5 teaching cases (1 benchmark case and 4 teaching cases), an interactive knowledge module (IKM) and a performance grading system. The tutoring program started with the benchmark case completed by each trainee independently to benchmark the baseline skill level. This same case was re-tested to evaluate the performance and clinical planning readiness after the trainee completes the tutoring program. 4 teaching cases were included: simple (1), intermediate (2) and complex (1). All 5 cases have simultaneous integrated boost prescription of 25Gy to the elective volume and 33Gy to the gross tumor volume. The IKM included a dose-volume prediction knowledge model for pancreas SBRT and is integrated via a graphic user interface in the treatment planning system. The trainee can seek reference and guidance from the IKM during learning – mimicking the hands-on tutoring of human expert. The grading system summarize the plan quality by weighing key dosimetric endpoints and their relative importance. Grade point average (GPA) was introduced to qualitatively appraise the plan quality into A, B and C (within 3%, 3-10% and > 10% difference of clinical plan score, corresponding to 4, 3, 2 point respectively). 5 trainees with minimum planning experience completed the teaching course. <h3>Results</h3> Trainees achieved an average of 65.1% of total points (3.6 GPA) with 84 minutes planning time for the benchmark case pre-teaching, and improved to an average of 75.7% (4.2 GPA) using 48 minutes post-teaching. The clinical plan scored 72.7% of total points. All trainees improved their teaching plans' scores after taking the virtual tutoring program. Post-teaching, all trainees received the GPA of A (clinical quality level) on the benchmark case planning. The total teaching time for each trainee ranged between 5 and 7 hours. <h3>Conclusion</h3> The tutoring program with knowledge support modules provides encouraging learning outcomes in pancreas SBRT planning for inexperienced planners. This AI-enabled virtual teaching tool could provide valuable addition to the traditional human resource heavy in-person teaching of IMRT and SBRT treatment planning.

A Practical Method to Prolong Expiratory Breath Holds for Abdominal Stereotactic Body Radiotherapy

Motion management is crucial to safe and efficacious treatment for abdominal stereotactic body radiotherapy (SBRT). Expiratory breath hold (EBH) treatment is attractive as it does not require sophisticated gating technologies and minimizes abdominal target motion compared to inspiratory breath hold and abdominal compression; however, few patients can perform prolonged EBH to allow efficient treatment. We hypothesized that providing patients supplemental oxygen and controlling respiratory rate (RR) at the upper limit of normal would improve EBH times, increase the percentage of patients eligible for EBH treatment and decrease EBH treatment time.Starting in 2020, we provided patients supplemental oxygen (50% O2 via Venturi mask) with synchronization to a RR of 18 breaths/min with a metronome at the time of CT simulation. Patients were eligible for EBH treatment if they were able to complete two consecutive 20 second EBH. Eligible patients were treated per standard institutional guidelines for abdominal SBRT with EBH. We retrospectively identified all completed EBH treatments with this new supplemented procedure (EBHsupp) from our departmental database. Historical controls treated with EBH prior to this new procedure (EBHRA, where RA = room air) were identified and matched 1:1 based on patient age, sex, RT prescription, number of treatment arcs, and comorbidities via individual matching. Individual patient EBH times, total treatment time, cone beam CT (CBCT) time, and treatment arc time were extracted from the treatment planning software. Statistical comparisons were made with chi-squared test for categorical variables and student's t-test for continuous variables.We identified 8 patients that received 10 abdominal SBRT treatment plans with EBHsupp (two patients had two lesions requiring two separate treatment plans). There was no statistical difference between the EBHsupp and EBHRA groups with respect to patient characteristics. Eight of 11 (73%) screened EBHsupp patients were able to undergo EBH treatment compared to historical department standard of ∼30% with EBHRA. The EBHsupp group had a significant improvement in maximum (50.5 vs 30.9 s, P = 0.002) and median (24.0 vs 17.8 s, P = 0.016) EBH times compared to the EBHRA group and required less breath holds to complete their treatment (9.1 vs 13.9, P = 0.029). Time for CBCT was reduced with EBHsupp (6.5 vs 8.6 min, P = 0.004) and there was a trend towards decreased time for treatment arc completion (3.1 vs 4.0 min, P = 0,10) and overall treatment time (18.6 vs 21.7 min, P = 0.12).Providing supplemental oxygen and controlling respiratory rate at 18 breaths/min significantly improves EBH time. This intervention is simple, inexpensive, safe, and may allow more patients to be treated with EBH while decreasing overall treatment time.C.S. Schneider: None. S. Shen: None. J.B.Fiveash: None. R. Jacob: None.

Cardiac Motion and its Impact on Target Coverage During SBRT for Refractory Ventricular Tachycardia

<h3>Purpose/Objective(s)</h3> Refractory ventricular tachycardia (VT) is a common cause of death and morbidity in the heart failure population. Stereotactic body radiation therapy (SBRT) is a new and promising approach to treating VT, but there are practical concerns about SBRT delivery to the heart, which undergoes motion from both cardiac and respiratory cycles. In this study, we investigate motion magnitudes from both cycles and their impact on treatment margins and target coverage for VT SBRT. <h3>Materials/Methods</h3> Twenty-one patients were treated with SBRT for VT at our institution between April 2018 and December 2020 under an IRB-approved registry protocol. All patients had respiratory-correlated 4DCT for treatment planning and 7 patients had diagnostic cardiac-gated CT scans taken less than two weeks prior to treatment. Target structures were delineated on free-breathing CT and transferred to respiratory average (RAVG) CT via rigid registration. Dose was initially calculated on the RAVG per current institutional standard of care. For this retrospective study, deformable image registration (DIR) was applied between RAVG and the cardiac average CT (CAVG), systolic, and diastolic CTs from the cardiac dataset. Target contours were transferred to the registration target image. Motion magnitudes and distributions from the deformation vector fields were analyzed. Internal target volumes (ITVs) were created on the respiratory average images for quantitative analysis of target motion and coverage changes. From these 7 patients, 11 distinct target volumes were treated, with 8 being epicardial and 3 endocardial. Motion and dosimetry for all 11 targets were analyzed separately. <h3>Results</h3> The average (SD) target shift magnitudes (in mm) from the RAVG to CAVG CTs were 2.0 ± 1.0, 2.0 ± 1.3, and 4.0 ± 2.0 in the left-right (LR), anterior/posterior (AP), and superior/inferior (SI) directions. Endocardial targets had greater motion magnitude than epicardial targets, with mean shifts of 2.2 ± 1.0, 2.3 ± 1.9, and 4.2 ± 2.4 in the LR, AP, and SI directions versus 1.4 ± 0.9, 1.3 ± 0.8, and 3.6 ± 0.5. Cardiac cycle motion showed more variability for epicardial targets with shifts of 1.4 ± 2.5, 2.4 ± 3.0, and 2.5 ± 3.7 in the LR, AP and SI directions, versus 2.0 ± 0.6, 2.1 ± 0.8, and 1.6 ± 0.7 for endocardial targets. Creation of motion encompassing ITVs led to an average target size increase of 100% (25 cm³). V95 for initial target volumes was 99.9 ± 0.4% while the average V95 for ITVs was 84.1 ± 15.6%. Similarly, D95 for the target dropped from 108.2 ± 5.7% to 75.3 ± 28.4%. <h3>Conclusion</h3> In this cohort of patients undergoing SBRT for VT, cardiac shifts were location-dependent and were largest in the SI direction. These shifts typically exceeded the 1-5 mm margins used for SBRT treatment planning and ITV generation to encompass all target motion led to a doubling in target size. Our data suggest that cardiac-gated delivery may be helpful to minimize treatment volumes and spare cardiac tissue.

Determining Radiation Doses of Critical Normal Tissues for Stereotactic Body Radiotherapy (SBRT) of Central Lung Tumors

While respiratory motion is included in the definition of target volumes for lung SBRT, delineation of organs at risk (OARs) and dose calculation are typically performed on average intensity projection images (AIP). This approach often misses structural detail during contouring due to motion blurring on AIP. Including respiratory motion in the dose calculation for OARs will result in more accurate dose assessment, which is necessary to establish reliable dose-effect relationships, particularly for SBRT of central lung tumors with a high risk of critical side effects.For 17 centrally-located lung tumors, clinical 4DCT-based SBRT treatment plans (BED≥100 Gy in 76%) were created for both AIP and mid ventilation image (MidV, 30% breathing phase) and contour sets. Internal GTVs were produced via GTV propagation over all breathing phases. OARs were outlined on both AIP and MidV images according to RTOG 0813. Both plans were also recalculated on all 10 breathing phases and registered back deformably to the MidV to assess differences in the accumulated OAR doses over the full breathing cycle. MidV was selected over the AIP as the reference image for comparison as it does not suffer from motion blurring.Volumes were, on average, larger on AIP than MidV image sets for all OARs by 3-15% (P < 0.05 for heart, lungs, great vessels (GV)), except the esophagus. Mean differences ± SDs in the max doses (Gy) between respiration-averaged MidV and AIP plans were for proximal bronchial tree (PBT) 2.26 ± 2.11, heart 2.24 ± 2.89, GV 1.71 ± 1.12, esophagus 1.38 ± 1.1, spinal cord 1.11 ± 0.67, and trachea 0.71 ± 1.16. Doses were significantly different for heart Dmean/10cc/15cc (P = 0.03/0.03/0.04). Relative to MidV plans, AIP plans resulted in higher max doses for PBT in 11/17 (65%) plans, 9/17 (53%) for esophagus, GV and spinal cord, and 5/17 (29%) for heart and trachea. Max dose differences > 5 Gy were observed for GV and PBT in 2/17 (12%) and for heart in 3/17 (18%) of individual plans. Superior-inferior carina motion ranged from 0.32 to 0.73 cm. No significant correlations between dose differences and carina motion were identified.Though limited by a small sample size, this study represents a comprehensive assessment of OAR doses for SBRT planning of centrally located lung tumors including the effects of respiratory motion. We often observed only small differences in dose delivered to central OARs. However, clinically relevant differences ≥ 5 Gy were observed in individual patients for PBT, GV and heart, resulting in over- or underestimation of the actual OAR dose over the full breathing cycle when using AIP-based planning. We therefore recommend MidV image-based OAR dose assessment to develop reliable dose-effect relationships for central lung OARs.D.A. Cooper: None. L. Padilla: None. A. Watson: None. K. Neiderer: None. B. Smith: None. E. Weiss: Research Grant; NIH. royalties; UpToDate.